Study to assess relative bioavailability and safety of AZD5718 in healthy volunteers

Trial Identifier:	D7551C00003
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT04734275
Start Date:	February 2021
Primary Completion Date:	March 2021
Study Completion Date:	March 2021
Condition:	Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.